Aminaphtone appears to reduce the transcription and protein production of key inflammatory mediators, including IL-6 [6,10], and it also lowers TGF-β levels, which can contribute to pulmonary fibrosis by stimulating fibroblasts to excessively deposit collagen [5,6,7]. The gene discussed is TGFB1; the disease is pulmonary fibrosis.